Evaluation of Selective COX-2 Inhibitors for the Treatment of Alzheimer's Disease
Open Access
- 1 April 2002
- journal article
- review article
- Published by Elsevier
- Vol. 23 (4) , S35-S40
- https://doi.org/10.1016/s0885-3924(02)00374-3
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's diseaseJournal of Neuroscience Research, 1999
- Maturational Regulation and Regional Induction of Cyclooxygenase-2 in Rat Brain: Implications for Alzheimer's DiseaseExperimental Neurology, 1997
- Inflammation and Alzheimer’s Disease: Mechanisms and Therapeutic StrategiesGerontology, 1997
- Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB ActivationScience, 1996
- IL-1 and anti-inflammatory drugs modulate A β cytotoxicity in PC12 cellsBrain Research, 1996
- Cyclooxygenase‐2 Induction in Cerebral Cortex: An Intracellular Response to Synaptic ExcitationJournal of Neurochemistry, 1996
- Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugsNeurobiology of Aging, 1995
- Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoidsNeuron, 1993
- Estimation of the in vivo effect of cyclooxygenase inhibitors on prostaglandin E2 levels in mouse brainEuropean Journal of Pharmacology, 1990
- Inhibition of Prostaglandin Synthesis in Rat BrainActa Pharmacologica et Toxicologica, 1978